Puma Biotechnology Boosted After FDA Approves Breast Cancer Therapy
July 18, 2017 at 08:25 AM EDT
The U.S. Food and Drug Administration on Monday approved Puma Biotechnology Inc (NASDAQ: PBYI)'s NERLYNX (neratinib), formerly known ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.